0000899243-18-022429.txt : 20180815 0000899243-18-022429.hdr.sgml : 20180815 20180815082522 ACCESSION NUMBER: 0000899243-18-022429 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180814 FILED AS OF DATE: 20180815 DATE AS OF CHANGE: 20180815 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chodakewitz Jeffrey CENTRAL INDEX KEY: 0001610876 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38359 FILM NUMBER: 181019785 MAIL ADDRESS: STREET 1: C/O TETRAPHASE PHARMACEUTICALS, INC. STREET 2: 480 ARSENAL ST., SUITE 101 CITY: WATERTOWN STATE: MA ZIP: 02472 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: resTORbio, Inc. CENTRAL INDEX KEY: 0001720580 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813305277 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 BOYLSTON STREET STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-482-2333 MAIL ADDRESS: STREET 1: 500 BOYLSTON STREET STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-08-14 0 0001720580 resTORbio, Inc. TORC 0001610876 Chodakewitz Jeffrey C/O RESTORBIO, INC. 500 BOYLSTON STREET, 12TH FLOOR BOSTON MA 02116 1 0 0 0 Stock Option (Right to Buy) 10.42 2018-08-14 4 A 0 28828 0.00 A 2028-08-14 Common Stock 28828 28828 D 33% of the shares shall vest on August 14, 2019, with the remainder vesting ratably monthly thereafter. /s/ Jeffrey Chodakewitz 2018-08-15